Finance

Lists
LABS:IDX
PT UBC Medical Indonesia Tbk
159,00 IDR
-1,85%
(-3,00) 1D
16 հոկ, 08:58:07 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for LABS...
Open
159 IDR
High
159 IDR
Low
159 IDR
Mkt. cap
628,05 մլրդ
Avg. vol.
5,09 մլն
Volume
76,60 հզր
P/E ratio
58,75
52-wk high
260 IDR
52-wk low
129 IDR
EPS
3 IDR
Shares outstanding
3,95 մլրդ
No. of employees
54
Open
159 IDR
High
159 IDR
Low
159 IDR
Mkt. cap
628,05 մլրդ
Avg. vol.
5,09 մլն
Volume
76,60 հզր
P/E ratio
58,75
52-wk high
260 IDR
52-wk low
129 IDR
EPS
3 IDR
Shares outstanding
3,95 մլրդ
No. of employees
54
News stories
From web sources and news partners
About PT UBC Medical Indonesia Tbk
CEO-
Employees54
Founded2014
Headquarters-
SectorHealth care provider
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
48,74 մլրդ
63,86 մլրդ
40,02 մլրդ
55,20 մլրդ
Cost of goods sold
27,68 մլրդ
38,97 մլրդ
21,51 մլրդ
34,56 մլրդ
Cost of revenue
27,68 մլրդ
38,97 մլրդ
21,51 մլրդ
34,56 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,09 մլրդ
16,63 մլրդ
17,67 մլրդ
14,25 մլրդ
Operating expense
15,09 մլրդ
17,40 մլրդ
17,67 մլրդ
14,25 մլրդ
Total operating expenses
42,77 մլրդ
56,38 մլրդ
39,18 մլրդ
48,81 մլրդ
Operating income
5,97 մլրդ
7,48 մլրդ
843,68 մլն
6,39 մլրդ
Other non operating income
97,39 մլն
-508,78 մլն
116,15 մլն
20,62 մլն
EBT including unusual items
4,91 մլրդ
5,56 մլրդ
409,62 մլն
3,83 մլրդ
EBT excluding unusual items
4,91 մլրդ
6,39 մլրդ
409,62 մլն
3,83 մլրդ
Income tax expense
-
4,02 մլրդ
-
-
Effective tax rate
-
72,23%
-
-
Other operating expenses
-
-
-
-
Net income
4,91 մլրդ
1,54 մլրդ
409,63 մլն
3,83 մլրդ
Net profit margin
10,07%
2,42%
1,02%
6,94%
Earnings per share
-
-
-
-
Interest and investment income
88,10 մլն
31,38 մլն
89,27 մլն
6,12 մլն
Interest expense
-275,82 մլն
-317,92 մլն
-229,81 մլն
-388,30 մլն
Net interest expenses
-187,72 մլն
-286,54 մլն
-140,54 մլն
-382,18 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
9,41 մլրդ
9,77 մլրդ
3,99 մլրդ
9,17 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps